Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Telemedicine facilitated the delivery of essential services for diabetes patients during the pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

A new coronavirus found in Swedish bank voles

Researchers report the discovery of the Gimso virus, a novel betacoronavirus in a bank vole from Grimso, Sweden

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

How do viruses evolve to infect new hosts?

Researchers discuss how protein thermostability prevents the misfolding of viral proteins from being heated.

7 Jun 2022

Review sets out new plans to create the biggest shake-up in health and social care leadership

The Health and Social Care Secretary Sajid Javid has welcomed the publication of an independent review of health and adult social care leadership, led by General Sir Gordon Messenger and Dame Linda Pollard - and, in what will be the biggest shake-up in health and social care leadership in a generation, is accepting all seven transformative recommendations they have put forward.

7 Jun 2022

Manufacturers and suppliers influence how pharmacies buy, distribute opioid prescriptions, study finds

In today's post-pandemic world, strained global supply chains have emerged as a new norm. But in the case of prescription opioids, namely oxycodone and hydrocodone in the early 2000s, that supply chain flowed freely without any kinks.

7 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

7 Jun 2022

De novo-designed mini-protein against SARS-CoV-2

Researchers characterized truncated forms of LCB1, a de novo-designed mini-protein, against SARS-CoV-2.

7 Jun 2022

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on influenza vaccination.

7 Jun 2022

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Researchers observed SARS-CoV-2 seroconversion in lactating cows.

7 Jun 2022

Omicron lineage spike proteins use ACE2 receptors more efficiently

A recent study posted to the bioRxiv* preprint server demonstrated various traits, including the entry pathways and sensitivity to vaccination-elicited antibody responses by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants.

7 Jun 2022

Pandemic News and Research

Further Reading

Telemedicine facilitated the delivery of essential services for diabetes patients during the pandemic

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

A new coronavirus found in Swedish bank voles

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Gastrointestinal complications caused by SARS-CoV-2

How do viruses evolve to infect new hosts?

Review sets out new plans to create the biggest shake-up in health and social care leadership

Manufacturers and suppliers influence how pharmacies buy, distribute opioid prescriptions, study finds

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

De novo-designed mini-protein against SARS-CoV-2

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Omicron lineage spike proteins use ACE2 receptors more efficiently

Monkeypox virus transmission via sexual contact

Can dogs accurately detect COVID-19?

New fluorogenic probe could quickly detect the presence of influenza A virus

Study evaluates the impact of COVID-19 pandemic on postpartum depression

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News